Mechanisms of resistance to EGFR tyrosine kinase inhibitors gefitinib/erlotinib and to ALK inhibitor crizotinib
Tartarone, Alfredo, Lazzari, Chiara, Lerose, Rosa, Conteduca, Vincenza, Improta, Giuseppina, Zupa, Angela, Bulotta, Alessandra, Aieta, Michele, Gregorc, VanesaVolume:
81
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/j.lungcan.2013.05.020
Date:
September, 2013
File:
PDF, 1.54 MB
english, 2013